Skip to content

Study On The Effect Of Masuradi Medicated Ghee orally And Eye Drops In Treating Short sightedness

A Randomized Open Label Controlled Clinical Study On The Efficacy Of Masuradi Ghritapana And Aschyotana In The Management Of Pratama Patalagata Timira With Special Reference To Simple Myopia - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106152
Enrollment
30
Registered
2026-03-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H521- Myopia

Interventions

None listed

Sponsors

Dr Chethana A
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects having signs and symptoms of Pratama Patalagata Timira. 2. Subjects who complain of mild to moderate difficulty in distant vision. (-0.5 D to -5 D). 3. Subjects with age group of 16-25 years, irrespective of gender, caste, religion, and socio-economic status. 4. Subjects who fulfil the diagnostic criteria. 5. Subjects who are ready to sign an informed consent form and parent assent form (for minors).

Exclusion criteria

Exclusion criteria: 1. Subjects diagnosed with pathological myopia and high myopia (more than 6/60) 2. Myopia associated with cataract, corneal opacity, keratoconus and Glaucoma. 3. Subjects having any uncontrolled systemic illness that can interfere with the course of disease and treatment 4. Subjects diagnosed with infective diseases of the eye like Conjunctivitis, Uveitis, Scleritis, Keratitis, Stye, Trachoma, Endophthalmitis, Blepharitis, Retinitis pigmentosa and Dacryocystitis. 5. Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
significant improvement in the signs and symptoms of pratama patalagata timira,simple myopiaTimepoint: Pre treatment 0th Day 1st assessment 8th Day Post treatment assessment 31st Day Follow up 1 45th Day Follow up 2 60th Day

Secondary

MeasureTime frame
Generation of in-depth analysed data on the different aspects of the disease. Generation of data on possible adverse drug reactions. Timepoint: Pre treatment 0th Day 1st assessment 8th Day Post treatment assessment 31st Day Follow up 1 45th Day Follow up 2 60th Day

Countries

India

Contacts

Public ContactDr Krishnan Namboodiri

Sri Sri College Of Ayurvedic Science and Research Hospital

krish555@gmail.com8089166191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026